Page 4 - Additional Information Will News Today

 По предварительным данным 11 августа при проведении инженерных исследований на территории общины Нор Шен Мартунинского района Республики Арцах в результате взрыва кассетной бомбы ранения получили саперы Фонда «Центр гуманитарного разминирования». Как со...

(0) The purchased credits help to clean 250,000 tons of carbon from the atmosphere Miami, Florida--(Newsfile Corp. - June 9, 2021) - Gryphon Digital Mining and Sphere 3D (NASDAQ: ANY), which recently entered into an Agreement and Plan of Merger, today announced that they have entered into an agreement to purchase 250,000 Certified Emission Reductions ("CERs" or "Credits"), with each company purchasing 125,000 credits, subject to closing conditions (as further defined below). These credits will ...

The purchased credits help to clean 250,000 tons of carbon from the atmosphere...

Transaction to Create a Nasdaq-listed 100% Renewable Energy, ESG-committed Crypto Miner Toronto, Ontario--(Newsfile Corp. - June 3, 2021) - Sphere 3D Corp. (NASDAQ: ANY) (the "Company" or "Sphere 3D")

Published: May 24, 2021 With this acquisition, Enveric will expand and complement its pipeline of naturally occurring cannabinoid compounds with a robust portfolio of psychedelic-derived molecules Enveric aims to move into the clinic with novel cannabinoid and psychedelic-derived therapies to improve standard of care and serve unmet needs across multiple indications including oncology and CNS, such as PTSD Upon closing, Dr. Joseph Tucker will be appointed Enveric Biosciences CEO and David J...

  Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, today announced that it has entered into a definitive agreement to acquire MagicMed Industries Inc. ("MagicMed"), a privately-held biotechnology company focused on creating a library of novel derivative psychedelic molecules such as psilocybin, N,N-dimethyltryptamine (DMT) and other molecular derivati...

Leading BioSciences and Seneca Biopharma Announce Merger GERMANTOWN, Md. and CARLSBAD, Calif., Dec. 17, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA) ("Seneca"), and Leading BioSciences, Inc. ("LBS"), a privately held company focused on developing novel therapeutics to improve human health through therapeutic protection of the gastrointestinal ("GI") mucosal barrier, announced today that they have entered into a definitive agreement under which a wholly owned subsidiary of Seneca w...